HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Zinc supplementation during pregnancy protects against lipopolysaccharide-induced fetal growth restriction and demise through its anti-inflammatory effect.

Abstract
LPS is associated with adverse developmental outcomes, including preterm delivery, fetal death, teratogenicity, and intrauterine growth restriction (IUGR). Previous reports showed that zinc protected against LPS-induced teratogenicity. In the current study, we investigated the effects of zinc supplementation during pregnancy on LPS-induced preterm delivery, fetal death and IUGR. All pregnant mice except controls were i.p. injected with LPS (75 μg/kg) daily from gestational day (GD) 15 to GD17. Some pregnant mice were administered zinc sulfate through drinking water (75 mg elemental Zn per liter) throughout the pregnancy. As expected, an i.p. injection with LPS daily from GD15 to GD17 resulted in 36.4% (4/11) of dams delivered before GD18. In dams that completed the pregnancy, 63.2% of fetuses were dead. Moreover, LPS significantly reduced fetal weight and crown-rump length. Of interest, zinc supplementation during pregnancy protected mice from LPS-induced preterm delivery and fetal death. In addition, zinc supplementation significantly alleviated LPS-induced IUGR and skeletal development retardation. Further experiments showed that zinc supplementation significantly attenuated LPS-induced expression of placental inflammatory cytokines and cyclooxygenase-2. Zinc supplementation also significantly attenuated LPS-induced activation of NF-κB and MAPK signaling in mononuclear sinusoidal trophoblast giant cells of the labyrinth zone. It inhibited LPS-induced placental AKT phosphorylation as well. In conclusion, zinc supplementation during pregnancy protects against LPS-induced fetal growth restriction and demise through its anti-inflammatory effect.
AuthorsYuan-Hua Chen, Mei Zhao, Xue Chen, Ying Zhang, Hua Wang, Ying-Ying Huang, Zhen Wang, Zhi-Hui Zhang, Cheng Zhang, De-Xiang Xu
JournalJournal of immunology (Baltimore, Md. : 1950) (J Immunol) Vol. 189 Issue 1 Pg. 454-63 (Jul 01 2012) ISSN: 1550-6606 [Electronic] United States
PMID22661087 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Anti-Inflammatory Agents, Non-Steroidal
  • Lipopolysaccharides
  • Zinc
Topics
  • Animals
  • Anti-Inflammatory Agents, Non-Steroidal (administration & dosage, therapeutic use)
  • Dietary Supplements (statistics & numerical data)
  • Female
  • Fetal Death (immunology, pathology, prevention & control)
  • Fetal Growth Retardation (mortality, pathology, prevention & control)
  • Fetal Monitoring (methods, mortality)
  • Lipopolysaccharides (antagonists & inhibitors, toxicity)
  • Male
  • Mice
  • Mice, Inbred ICR
  • Pregnancy
  • Premature Birth (mortality, pathology, prevention & control)
  • Random Allocation
  • Zinc (administration & dosage, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: